Regenerative Medical Technology (RMTG) Total Liabilities (2017 - 2026)

Regenerative Medical Technology has reported Total Liabilities for 10 years, with the latest figure at $45.1 million in Q2 2026.

• On a quarterly basis, Total Liabilities rose 34.61% year-over-year to $45.1 million in Q2 2026; TTM through Jun 2026 was $45.1 million, a 34.61% increase from a year earlier, with the FY2025 full-year figure at $40.5 million, up 30.02% from the prior year.
• Total Liabilities was $45.1 million for Q2 2026 at Regenerative Medical Technology, up from $40.6 million in the prior quarter.
• The five-year high for Total Liabilities was $45.1 million in Q2 2026, with the low at $17.1 million in Q1 2022.
• Average Total Liabilities over 5 years is $28.5 million, with a median of $27.9 million recorded in 2024.
• The largest YoY upside for Total Liabilities was 139.18% in 2022 against a maximum downside of 14.8% in 2022.
• Over 5 years, Total Liabilities stood at $20.1 million in 2022, then increased by 22.99% to $24.7 million in 2023, then gained by 26.36% to $31.2 million in 2024, then jumped by 30.02% to $40.5 million in 2025, then rose by 11.27% to $45.1 million in 2026.
• The last three Total Liabilities figures came in at $45.1 million (Q2 2026), $40.6 million (Q1 2026), and $40.5 million (Q4 2025), per Business Quant data.